J. Carter

发表

Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease

P. Porter, S. Schwartz, D. Galloway, 2005, International journal of cancer.

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies

Aaron M. Seese, Abigail Wall, A. McGuire, 2020, Journal of Immunological Methods.

Re‐detection vs. new acquisition of high‐risk human papillomavirus in mid‐adult women

S. Schwartz, J. Hughes, D. Galloway, 2016, International journal of cancer.

No Evidence for Human Papillomavirus in the Etiology of Colorectal Polyps

J. Potter, P. Newcomb, S. Schwartz, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.

D. Galloway, R. Garg, Q. Feng, 2011, The Journal of infectious diseases.

Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.

D. Galloway, P. Nghiem, D. Schrama, 2010, Cancer research.

Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.

N. Weiss, J. Hughes, D. Galloway, 2009, The Journal of infectious diseases.

Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.

P. Porter, S. Schwartz, B. McKnight, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.

J. Dillner, D. Galloway, N. Christensen, 1996, Virology.

Lack of serologic evidence for prevalent simian virus 40 infection in humans.

R. Garcea, D. Galloway, P. Minor, 2004, Journal of the National Cancer Institute.

Cohort profile: the skin cancer after organ transplant study.

S. Schwartz, D. Galloway, J. Daling, 2013, International journal of epidemiology.

The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.

S. Schwartz, B. McKnight, D. Galloway, 2000, Cancer Epidemiology, Biomarkers and Prevention.

Cervical and Vulvar Cancer Risk in Relation to the Joint Effects of Cigarette Smoking and Genetic Variation in Interleukin 2

S. Schwartz, D. Galloway, M. Malkki, 2008, Cancer Epidemiology Biomarkers & Prevention.

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)

D. Galloway, D. Doody, M. Madeleine, 2016, Journal of lower genital tract disease.

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

P. Porter, S. Schwartz, D. Galloway, 2004, Cancer.

Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.

P. Porter, S. Schwartz, D. Galloway, 2001, Cancer research.

The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.

S. Schwartz, M. Hagensee, B. McKnight, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Age of Diagnosis of Squamous Cell Cervical Carcinoma and Early Sexual Experience

S. Schwartz, J. Hughes, D. Galloway, 2009, Cancer Epidemiology Biomarkers & Prevention.

A population-based study of squamous cell vaginal cancer: HPV and cofactors.

P. Porter, S. Schwartz, B. McKnight, 2002, Gynecologic oncology.

Humoral immune response to human papillomavirus infection.

D. Galloway, J. Carter, Joseph J. Carter, 1997, Clinics in dermatology.

The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.

S. Schwartz, B. McKnight, D. Galloway, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination

D. Galloway, J. Carter, P. Prabhu, 2022, Vaccines.

Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes

M. Daugherty, Kristin L. Robinson, D. Galloway, 2013, Proceedings of the National Academy of Sciences.

Human Papillomavirus and Long-term Oral Contraceptive Use Increase the Risk of Adenocarcinoma in Situ of the Cervix 1

P. Porter, S. Schwartz, B. McKnight, 2001 .

Cancer esearch oenvironment and Immunology ibodies to Merkel Cell Polyomavirus T Antigen oproteins Reflect Tumor Burden in Merkel R l Carcinoma Patients

D. Galloway, P. Nghiem, D. Schrama, 2010 .

Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.

J. Cerhan, P. Hartge, S. de Sanjosé, 2004, Journal of the National Cancer Institute.

Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood

Olga K Afanasiev, D. Byrd, C. Yee, 2011, Clinical Cancer Research.

Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

D. Galloway, N. Christensen, P. Randhawa, 2009, The Journal of general virology.

Short Communication Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies

D. Galloway, N. Christensen, P. Randhawa, 2009 .

HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts.

M. Hagensee, D. Galloway, L. Koutsky, 1993, Virology.

Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development

N. Kiviat, K. Jansen, J. Hughes, 2009, Journal of medical virology.

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study

D. Galloway, M. Wener, P. Nghiem, 2017, Cancer.

Identification of a Human Papillomavirus Type 16-Specific Epitope on the C-Terminal Arm of the Major Capsid Protein L1

D. Galloway, N. Christensen, J. Carter, 2003, Journal of Virology.

Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study

D. Colombara, Y. Qiao, N. Weiss, 2015, Cancer Causes & Control.

A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects

N. Trinklein, A. Wald, D. Galloway, 2016, EBioMedicine.

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma

D. Galloway, P. Nghiem, M. Madeleine, 2009, Journal of the National Cancer Institute.

Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies.

M. Hagensee, D. Galloway, J. Carter, 1995, Virology.

Cofactors with human papillomavirus in a population-based study of vulvar cancer.

S. Schwartz, M. Hagensee, B. McKnight, 1997, Journal of the National Cancer Institute.

Characteristics of Memory B Cells Elicited by a Highly Efficacious HPV Vaccine in Subjects with No Pre-existing Immunity

D. Galloway, E. Scherer, J. Carter, 2014, PLoS pathogens.

Skin and Mucosal Human Papillomavirus Seroprevalence in Persons with Fanconi Anemia

D. Galloway, P. Mehta, J. Stern, 2015, Clinical and Vaccine Immunology.

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.

S. Schwartz, D. Galloway, J. McDougall, 1998, Journal of the National Cancer Institute.

Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts.

K. Holmes, N. Kiviat, M. Hagensee, 1995, The Journal of infectious diseases.

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

N. Kiviat, D. Galloway, N. Christensen, 1996, The Journal of infectious diseases.

Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study

D. Colombara, P. Taylor, Y. Qiao, 2016, BMC Cancer.

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants

S. Schwartz, D. Galloway, J. Daling, 2014, Cancer medicine.

Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study

D. Colombara, P. Taylor, Y. Qiao, 2016, BMC Cancer.

Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer.

J. Stanford, K. Rosenblatt, D. Galloway, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.

N. Kiviat, J. Hughes, D. Galloway, 2000, The Journal of infectious diseases.

Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine

A. Wald, D. Galloway, E. Scherer, 2017, The Journal of infectious diseases.

Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts.

B. McKnight, D. Galloway, L. Koutsky, 1994, Virology.

Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women

D. Galloway, S. Hawes, Q. Feng, 2016, Sexually transmitted diseases.

Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students.

N. Kiviat, J. Hughes, D. Galloway, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Identification of Human Papillomavirus Type 16 L1 Surface Loops Required for Neutralization by Human Sera

S. Schwartz, D. Galloway, L. Koutsky, 2006, Journal of Virology.

Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers

D. Galloway, L. Koutsky, J. Carter, 2005, Journal of Virology.

Stopping HPVs dead in their tracts.

D. Galloway, J. Carter, 2010, Cell host & microbe.

Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors

M. Leinonen, P. Saikku, S. Schwartz, 2007, International journal of cancer.

Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae.

D. Galloway, N. Yaegashi, J. Carter, 1991, Virology.

Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university women.

J. Hughes, D. Galloway, L. Koutsky, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.